UNBX (Unity Biotechnology) Total Operating Expense: $27.76 Mil (TTM As of Mar. 2025)


What is Unity Biotechnology Total Operating Expense?

Unity Biotechnology UNBX Total Operating Expense is $27.76 Mil as of Mar. 2025.

Unity Biotechnology's Total Operating Expense for the three months ended in Mar. 2025 was $6.89 Mil. Unity Biotechnology's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was $27.76 Mil.

Unity Biotechnology Total Operating Expense Related Terms

Unity Biotechnology Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Unity Biotechnology's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unity Biotechnology Total Operating Expense Chart

Unity Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only 91.33 61.45 57.81 39.07 28.47

Unity Biotechnology Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.60 6.98 6.60 7.29 6.89

Unity Biotechnology Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $27.76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $27.76 Mil mean?
Unity Biotechnology (UNBX) has a Total Operating Expense of $27.76 Mil as of Mar. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Unity Biotechnology and its competitors.
Is Unity Biotechnology's Total Operating Expense too high?
Unity Biotechnology's current Total Operating Expense is $27.76 Mil.
How does Unity Biotechnology's Total Operating Expense compare to ADTX and HEPA?
Unity Biotechnology's Total Operating Expense of $27.76 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Unity Biotechnology and its competitors. Unity Biotechnology's current Total Operating Expense is $27.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unity Biotechnology stock overvalued right now?
Unity Biotechnology (UNBX) has a current Total Operating Expense of $27.76 Mil. The current Total Operating Expense is $27.76 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Unity Biotechnology (UNBX), the current Total Operating Expense is $27.76 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Unity Biotechnology Business Description

Address 285 East Grand Avenue, South San Francisco, CA, USA, 94080
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.